Your browser doesn't support javascript.
loading
Pushing the CART to the Finish Line: Integrating Radiation Therapy Into Chimeric Antigen Receptor T-Cell Therapy Programs to Improve Outcomes for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma.
Parikh, Rahul R; Milgrom, Sarah A; Campbell, Belinda A.
Affiliation
  • Parikh RR; Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey. Electronic address: parikhrr@cinj.rutgers.edu.
  • Milgrom SA; Department of Radiation Oncology, University of Colorado, Aurora, Colorado.
  • Campbell BA; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia; Department of Clinical Pathology, University of Melbourne, Parkville, Victoria, Australia.
Int J Radiat Oncol Biol Phys ; 118(5): 1152-1158, 2024 Apr 01.
Article in En | MEDLINE | ID: mdl-38492961
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Lymphoma, Large B-Cell, Diffuse / Receptors, Chimeric Antigen Limits: Humans Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2024 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Lymphoma, Large B-Cell, Diffuse / Receptors, Chimeric Antigen Limits: Humans Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2024 Document type: Article